ArticleHaematologica2024

Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in <I>de novo</I> large B-cell lymphoma and transformed low-grade B-cell lymphoma.

Ohad Benjamini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.